Bakun P, Mlynarczyk DT, Koczorowski T, Cerbin-Koczorowska M, Piwowarczyk L, Kolasinski E, Stawny M, Kuzminska J, Jelinska A, Goslinski T
doi: 10.1038/nrendo.2015.128 37
You can resume your daily activities immediately after the treatment
In summary, we provide initial real-world evidence of reduced alcohol consumption in people with obesity taking Semaglutide or Tirzepatide medications, suggesting potential efficacy for treatment in AUD comorbid with obesity. Note: Beyond what is publicly available today, several studies from established research groups showing substantial anti-addictive effects have been submitted to journals and will be published in mid-2024
A qualified clinic will create a personalized treatment plan, provide high-quality peptides, and monitor your progress, which is the only way to ensure this therapy is right for you